FindTrial
Sign In

Study of blood coagulation profile to predict the risk of complications in high risk pregnancy

Coagulation profile in low and high risk pregnant women in third trimester of gestation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/034998
Enrollment
100
Registered
2021-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: NIL: NIL Control Intervention2: NIL: NIL

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All low and high risk pregnant women in third trimester gestation period from 29th to 40th week of pregnancy

Exclusion criteria

Exclusion criteria: Patient taking drugs that could affect coagulation profile

Design outcomes

Primary

MeasureTime frame
Assess the Prothrombin time, Activated partial thromboplastin time, Thrombin time, International normalized ratio(INR), Fibrinogen, Fibrin degradation products(FDP), D-Dimer levels in low and high risk pregnant women.Timepoint: 1 year—

Secondary

MeasureTime frame
Assess the association between altered coagulation profile and pregnancy complications such as Postpartum haemorrhage, Intrauterine death, Deep vein thrombosis and other Venous thromboembolismTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Sarika Singh

Maulana Azad Medical College Delhi

sarikasingh97b@gmail.com9911182326

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026